Urgent site urgencyFDA Class I

Vitamin Supplement (Vial) D3, (cholecalciferol (vit D3)/lipoic acid/ubiquinol/ methylcobalamin/pyridoxine/methionine/inositol/choline bitartrate USP) capsules, 60, 120 or 180 count

Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).

Agency
FDA Drug
Recall date
Nov 6, 2015
Status
Ongoing
Company
Glades Drugs Inc.

1. What product was recalled?

Vitamin Supplement (Vial) D3, (cholecalciferol (vit D3)/lipoic acid/ubiquinol/ methylcobalamin/pyridoxine/methionine/inositol/choline bitartrate USP) capsules, 60, 120 or 180 count

Vitamin Supplement (Vial) D3, (cholecalciferol (vit D3)/lipoic acid/ubiquinol/ methylcobalamin/pyridoxine/methionine/inositol/choline bitartrate USP) capsules, 60, 120 or 180 count vials, Glades Drugs, 109 S. Lake Ave., Pahokee, FL 33476.

Quantity: 7800 capsules

Code or lot text: AICACABF@3, AICECABF@2, AJBFCABF@4, ABCCABF@4, AICACABF@5, AICECABF@3, AJBHCABF@2, ABCCABF@5, AICBCABF@1, AICECABF@4, AJCBCABF@1, ABGCABF@4, AICBCABF@2, AICECABF@5, JCBCABF@2, BACDCABF@5, AICBCABF@3, AICICABF@3, BAAGCABF@2, BADACABF@3, AICBCABF@4, AJADCABF@1, BAAICABF@1, BACCABF@3, AICECABF@1, AJBECABF@6, BABCCABF@2 and BBAECABF@5, Exp 02/20/2016

LOT
ABCCABF@4
LOT
ABCCABF@5
LOT
ABGCABF@4
LOT
AICACABF@3
LOT
AICACABF@5
LOT
AICBCABF@1
LOT
AICBCABF@2
LOT
AICBCABF@3
LOT
AICBCABF@4
LOT
AICECABF@1
LOT
AICECABF@2
LOT
AICECABF@3
LOT
AICECABF@4
LOT
AICECABF@5
LOT
AICICABF@3
LOT
AJADCABF@1
LOT
AJBECABF@6
LOT
AJBFCABF@4
LOT
AJBHCABF@2
LOT
AJCBCABF@1
LOT
BAAGCABF@2
LOT
BAAICABF@1
LOT
BABCCABF@2 and BBAECABF@5
LOT
BACCABF@3
LOT
BACDCABF@5
LOT
BADACABF@3
LOT
Exp 02/20/2016
LOT
JCBCABF@2
RECALL-NUMBER
D-0669-2016

2. Is my exact product affected?

Compare every printed identifier. A matching value can indicate that your product is included.

3. What is the hazard?

Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).

4. What should I do now?

Follow the FDA recall notice and contact the recalling company for current instructions.

5. Where was it sold or distributed?

Georgia, New York

View source evidence for state distribution
  • Georgia: New York and Georgia
  • New York: New York and Georgia

6. Were injuries or illnesses reported?

No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.

7. What remedy is available?

Follow the FDA recall notice and contact the recalling company for current instructions.

8. Is the recall active or closed?

The source status is Ongoing. Recall Index urgency is urgent, which is a separate deterministic site label.

9. When was the information checked?

Last checked .

  1. created

10. Where is the official source?

Open the official FDA Drug source

Recall Index normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.